The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy

Phospholamban (PLN) plays a role in cardiomyocyte calcium handling as primary inhibitor of sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA). The p.(Arg14del) pathogenic variant in the PLN gene results in a high risk of developing dilated or arrhythmogenic cardiomyopathy with heart failure. There is...

Descripción completa

Detalles Bibliográficos
Autores principales: Eijgenraam, Tim R., Boukens, Bastiaan J., Boogerd, Cornelis J., Schouten, E. Marloes, van de Kolk, Cees W. A., Stege, Nienke M., te Rijdt, Wouter P., Hoorntje, Edgar T., van der Zwaag, Paul A., van Rooij, Eva, van Tintelen, J. Peter, van den Berg, Maarten P., van der Meer, Peter, van der Velden, Jolanda, Silljé, Herman H. W., de Boer, Rudolf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300032/
https://www.ncbi.nlm.nih.gov/pubmed/32555305
http://dx.doi.org/10.1038/s41598-020-66656-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300032/
https://www.ncbi.nlm.nih.gov/pubmed/32555305
http://dx.doi.org/10.1038/s41598-020-66656-9

Ejemplares similares